M. Quinlivan

发表

An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella‐zoster virus

A. Gershon, J. Breuer, S. Steinberg, 2005, Journal of medical virology.

Vaccine-Associated Herpes Zoster Opthalmicus and Encephalitis in an Immunocompetent Child

M. Theodoridou, J. Breuer, G. Chouliaras, 2010, Pediatrics.

Acknowledgements and Disclaimer

J. Mindell, A. Hayward, E. Fragaszy, 2015, World Trade Report.

Novel Genetic Variation Identified at Fixed Loci in ORF62 of the Oka Varicella Vaccine and in a Case of Vaccine-Associated Herpes Zoster

N. Jensen, D. Schmid, M. Quinlivan, 2012, Journal of Clinical Microbiology.

Subclinical VZV reactivation in immunocompetent children hospitalized in the ICU associated with prolonged fever duration.

I. Papassotiriou, J. Breuer, V. Papaevangelou, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Molecular studies of the Oka varicella vaccine

J. Breuer, D. Schmid, M. Quinlivan, 2011, Expert review of vaccines.

DNA sequence variability in Oka vaccine isolates.

R. Nichols, A. Gershon, J. Breuer, 2007, The Journal of infectious diseases.

Molecular and therapeutic aspects of varicella–zoster virus infection

J. Breuer, M. Quinlivan, 2005, Expert Reviews in Molecular Medicine.

The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation.

M. Peiris, P. Aaby, K. Yamanishi, 2002, The Journal of infectious diseases.

Viral load and antibody boosting following herpes zoster diagnosis

H. Forbes, J. Breuer, C. Warren-Gash, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Molecular studies of Varicella zoster virus

J. Breuer, M. Quinlivan, 2006, Reviews in medical virology.

Genotyping of Varicella-Zoster Virus and the Discrimination of Oka Vaccine Strains by TaqMan Real-Time PCR

J. Breuer, Y. Taha, S. Parker, 2006, Journal of Clinical Microbiology.

Are false negative direct immnufluorescence assays caused by varicella zoster virus gE mutant strains?

J. Breuer, M. Leedham-Green, Y. Taha, 2004, Journal of medical virology.

Debilitating Clinical Disease in a Wild-Born Captive Western Lowland Gorilla (Gorilla gorilla gorilla) Co-Infected with Varicella Zoster Virus (VZV) and Simian T-Lymphotropic Virus (STLV)

H. Niphuis, M. Stidworthy, J. Breuer, 2010, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.

A. Gershon, J. Breuer, S. Steinberg, 2004, The Journal of infectious diseases.

Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts

R. Nichols, P. LaRussa, A. Gershon, 2007, Proceedings of the National Academy of Sciences.

Herpes Zoster and in a Case of Vaccine-Associated Loci in ORF 62 of the Oka Varicella Vaccine Novel Genetic Variation Identified at Fixed

N. Jensen, S. Schmid, M. Quinlivan, 2012 .

Population diversity in batches of the varicella Oka vaccine.

R. Nichols, A. Gershon, J. Breuer, 2011, Vaccine.

Persistence of varicella-zoster virus viraemia in patients with herpes zoster.

Patrick J. Kelly, Robert W. Johnson, K. Ayres, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Effect of Viral Load on the Outcome of Herpes Zoster

K. Ayres, J. Breuer, M. Leedham-Green, 2007, Journal of Clinical Microbiology.

Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).

J. Breuer, M. Quinlivan, M. Essevaz-Roulet, 2010, Vaccine.

A case of nosocominal VZV transmission.

J. Breuer, M. Quinlivan, F. Scott, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual.

J. Breuer, Y. Taha, D. Syndercombe Court, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.

J. Breuer, M. Leedham-Green, Y. Taha, 2007, The Journal of infectious diseases.

Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus.

T. Ng, D. Depledge, S. Jacobsen, 2020, Virology.

The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme

K. Brown, A. Gershon, J. Breuer, 2016, Epidemiology and Infection.

Anti-cytokine autoantibodies in postherpetic neuralgia

M. Iadarola, S. Holland, J. Kroin, 2015, Journal of Translational Medicine.

Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe.

I. Lutsar, A. Sauerbrei, J. Breuer, 2013, The Journal of infectious diseases.

A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus.

J. Breuer, N. Sengupta, M. Quinlivan, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE)

J. Mindell, A. Hayward, E. Fragaszy, 2015 .